Immune profiling of lupus miliaris disseminatus faciei and successful management with anti‐tumour necrosis factor therapy-Reference-Cited by-同舟云学术

Immune profiling of lupus miliaris disseminatus faciei and successful management with anti‐tumour necrosis factor therapy

Published:2021-05-25 Issue:5 Volume:46 Page:910-914
ISSN:0307-6938
Container-title:Clinical and Experimental Dermatology
language:en
Short-container-title:Clin Exp Dermatol

Author:

Alexanian C.¹,Liakos W.¹^ORCID,Toussi A.¹^ORCID,Kao J.¹,Cheng M. Y.¹,Wang E. A.²,Nava J.¹,Tran M.¹,Marusina A. I.¹,Merleev A. A.¹,Leal A. R.¹,Fung M. A.¹³^ORCID,Le S. T.¹,Luxardi G.¹,Maverakis E.¹

Affiliation:

1. Departments of Department of Dermatology University of CaliforniaDavis Sacramento CA USA

2. Department of Dermatology Stanford University School of Medicine Palo Alto CA USA

3. Department of Pathology University of CaliforniaDavis Sacramento CA USA

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ced.14684

Reference15 articles.

1. Lupus Miliaris Disseminatus Faciei With Isolated Axillary Involvement

2. Nosology and therapeutic options for lupus miliaris disseminatus faciei

3. The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments

4. Granulomatous Rosacea Versus Lupus Miliaris Disseminatus Faciei—2 Faces of Facial Granulomatous Disorder: A Clinicohistological and Molecular Study

5. Lupus miliaris disseminatus faciei

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of facial and axillary lupus miliaris with adalimumab;Annales de Dermatologie et de Vénéréologie;2024-09

2. A Comparative Study on Clinico-Histopathological Features of Granulomatous Rosacea and Lupus Miliaris Disseminatus Faciei;Annals of Dermatology;2024

3. Improvements in lupus miliaris disseminatus faciei after three-color (blue, red, and infrared) light-emitting diode monotherapy;JAAD Case Reports;2023-06

4. Lupus miliaris disseminatus faciei in a 10‐year‐old child: A case report and literature review;Journal of Cosmetic Dermatology;2022-07-19

5. Adalimumab;Reactions Weekly;2021-11